Actinium Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Actinium Pharmaceuticals patents 20 in total

Status Patent
Application
Utility: METHOD FOR TREATING CANCER USING A BCL-2 INHIBITOR IN CONJUNCTION WITH AN ALPHA-EMITTING RADIOIMMUNOTHERAPEUTIC External link
Filling date: 26 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER External link
Filling date: 26 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER External link
Filling date: 26 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES External link
Filling date: 26 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES External link
Filling date: 26 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS External link
Filling date: 26 Sep 2025 Issue date: 12 May 2022
Application
Utility: Antibodies Conjugated With Actinium-225 and Actinium-227, and Related Compositions and Methods External link
Filling date: 26 Sep 2025 Issue date: 28 Apr 2022
Application
Utility: STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS External link
Filling date: 26 Sep 2025 Issue date: 21 Apr 2022
Application
Utility: Methods for Treating Cancer Using Combinations of PARP Inhibitors and Antibody Radioconjugates External link
Filling date: 26 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: COMBINATION OF RADIOIMMUNOTHERAPY AND IMMUNE CHECKPOINT THERAPY IN THE TREATMENT OF CANCER External link
Filling date: 26 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJCTION WITH ACT-BASED CANCER THERAPIES External link
Filling date: 26 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A HEMATOLOGICAL MALIGNANCY External link
Filling date: 26 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: METHOD FOR TREATING CANCER USING A BCL-2 INHIBITOR IN CONJUNCTION WITH AN ALPHA-EMITTING RADIOIMMUNOTHERAPEUTIC External link
Filling date: 26 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: MOLECULES AND THEIR DERIVATIVES DIRECTED AGANIST CD45 External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES External link
Filling date: 26 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: COMBINATION THERAPY FOR TREATMENT OF A HEMATOLOGICAL DISEASE External link
Filling date: 26 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES External link
Filling date: 26 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTION WITH GENE-EDITED CELL-BASED THERAPIES External link
Filling date: 26 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: TREATMENTS FOR A HEMATOLOGICAL MALIGNANCY External link
Filling date: 26 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: LOW DOSE ANTIBODY-BASED METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES External link
Filling date: 26 Sep 2025 Issue date: 29 Aug 2019

Showing 1 to 20 of 20 patents.